(Q42606277)
Statements
1 reference
Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety study (English)
1 reference
1 reference
Armando Santoro
1 reference
Won-Young Tak
1 reference
Antonio Gasbarrini
1 reference
Massimo Colombo
1 reference
Ho-Yeong Lim
1 reference
Vincenzo Mazzaferro
1 reference
Reiner Wiest
1 reference
María Reig
1 reference
Andrea Wagner
1 reference
Luigi Bolondi
1 reference
25 June 2013
1 reference
1 reference
49
1 reference
16
1 reference
3412-3419
1 reference
Identifiers
1 reference
1 reference